Prevention and treatment of low back pain: evidence, challenges, and promising directions

  • Nadine E. Foster
  • , Johannes R. Anema
  • , Dan Cherkin
  • , Roger Chou
  • , Steven P. Cohen
  • , Douglas P. Gross
  • , Paulo H. Ferreira
  • , Julie M. Fritz
  • , Bart W. Koes
  • , Wilco C. Peul
  • , Judith A. Turner
  • , Chris G. Maher
  • , Rachelle Buchbinder
  • , Jan Hartvigsen
  • , Dan Cherkin
  • , Nadine E. Foster
  • , Chris G. Maher
  • , Lancet Low Back Pain Series Working Group
  • , Martin Underwood (Medlem af forfattergruppering)
  • , Maurits van Tulder (Medlem af forfattergruppering)
  • Johannes R. Anema (Medlem af forfattergruppering), Roger Chou (Medlem af forfattergruppering), Stephen P. Cohen (Medlem af forfattergruppering), Lucíola Menezes Costa (Medlem af forfattergruppering), Peter Croft (Medlem af forfattergruppering), Manuela Ferreira (Medlem af forfattergruppering), Paulo H. Ferreira (Medlem af forfattergruppering), Julie M. Fritz (Medlem af forfattergruppering), Stéphane Genevay (Medlem af forfattergruppering), Douglas P. Gross (Medlem af forfattergruppering), Mark J. Hancock (Medlem af forfattergruppering), Damian Hoy (Medlem af forfattergruppering), Jaro Karppinen (Medlem af forfattergruppering), Bart W. Koes (Medlem af forfattergruppering), Alice Kongsted (Medlem af forfattergruppering), Quinette Louw (Medlem af forfattergruppering), Birgitta Öberg (Medlem af forfattergruppering), Wilco C. Peul (Medlem af forfattergruppering), Glenn Pransky (Medlem af forfattergruppering), Mark Schoene (Medlem af forfattergruppering), Joachim Sieper (Medlem af forfattergruppering), Rob J. Smeets (Medlem af forfattergruppering), Judith A. Turner (Medlem af forfattergruppering), Anthony Woolf (Medlem af forfattergruppering)

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Abstract

Many clinical practice guidelines recommend similar approaches for the assessment and management of low back pain. Recommendations include use of a biopsychosocial framework to guide management with initial non-pharmacological treatment, including education that supports self-management and resumption of normal activities and exercise, and psychological programmes for those with persistent symptoms. Guidelines recommend prudent use of medication, imaging, and surgery. The recommendations are based on trials almost exclusively from high-income countries, focused mainly on treatments rather than on prevention, with limited data for cost-effectiveness. However, globally, gaps between evidence and practice exist, with limited use of recommended first-line treatments and inappropriately high use of imaging, rest, opioids, spinal injections, and surgery. Doing more of the same will not reduce back-related disability or its long-term consequences. The advances with the greatest potential are arguably those that align practice with the evidence, reduce the focus on spinal abnormalities, and ensure promotion of activity and function, including work participation. We have identified effective, promising, or emerging solutions that could offer new directions, but that need greater attention and further research to determine if they are appropriate for large-scale implementation. These potential solutions include focused strategies to implement best practice, the redesign of clinical pathways, integrated health and occupational interventions to reduce work disability, changes in compensation and disability claims policies, and public health and prevention strategies.

OriginalsprogEngelsk
TidsskriftThe Lancet
Vol/bind391
Udgave nummer10137
Sider (fra-til)2368-2383
ISSN0140-6736
DOI
StatusUdgivet - 9. jun. 2018

Fingeraftryk

Dyk ned i forskningsemnerne om 'Prevention and treatment of low back pain: evidence, challenges, and promising directions'. Sammen danner de et unikt fingeraftryk.

Citationsformater